Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    March 2018
  1. TAKEUCHI H, Fathi A, Thiyanavadivel S, Agid O, et al
    Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    November 2017
  2. TSOUTSOULAS C, Mulsant BH, Kumar S, Ghazala Z, et al
    Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2017 Nov 28. doi: 10.4088/JCP.17m11523.
    PubMed     Text format     Abstract available


  3. ANDRADE C
    Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.17f11998.
    PubMed     Text format     Abstract available


  4. DEAN DJ, Bryan AD, Newberry R, Gupta T, et al
    A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.16m11365.
    PubMed     Text format     Abstract available


  5. MEKORI-DOMACHEVSKY E, Taler M, Shoenfeld Y, Gurevich M, et al
    Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    J Clin Psychiatry. 2017 Nov 14. pii: 16m11207. doi: 10.4088/JCP.16m11207.
    PubMed     Text format     Abstract available


  6. TINKELMAN A, Hill EA, Deligiannidis KM
    Management of New Onset Psychosis in the Postpartum Period.
    J Clin Psychiatry. 2017 Nov 7. pii: 17ac11880. doi: 10.4088/JCP.17ac11880.
    PubMed     Text format    


  7. DOWNS JM, Lechler S, Dean H, Sears N, et al
    The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.
    J Clin Psychiatry. 2017 Nov 7. pii: 16m11422. doi: 10.4088/JCP.16m11422.
    PubMed     Text format     Abstract available


  8. PERKINS DO
    Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
    J Clin Psychiatry. 2017;78:e1431.
    PubMed     Text format     Abstract available


    September 2017
  9. MCEVOY JP, Risinger R, Mykhnyak S, Du Y, et al
    Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.
    J Clin Psychiatry. 2017 Sep 19. pii: 17m11625. doi: 10.4088/JCP.17m11625.
    PubMed     Text format     Abstract available


  10. HAIG GM, Wang D, Zhao J, Othman AA, et al
    Efficacy and Safety of the alpha7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11162. doi: 10.4088/JCP.16m11162.
    PubMed     Text format     Abstract available


  11. PUIG O, Baeza I, de la Serna E, Cabrera B, et al
    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11122. doi: 10.4088/JCP.16m11122.
    PubMed     Text format     Abstract available


  12. SULTAN RS, Olfson M, Correll CU, Duncan EJ, et al
    Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    J Clin Psychiatry. 2017;78:e933-e939.
    PubMed     Text format     Abstract available


    June 2017
  13. WEIDEN PJ, Kim E, Bermak J, Turkoz I, et al
    Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
    J Clin Psychiatry. 2017 Jun 20. pii: 16m11308. doi: 10.4088/JCP.16m11308.
    PubMed     Text format     Abstract available


    May 2017
  14. WEISER M, Levi L, Burshtein S, Hagin M, et al
    Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2017 May 23. pii: 15m10498. doi: 10.4088/JCP.15m10498.
    PubMed     Text format     Abstract available


  15. TOSATO S, Albert U, Tomassi S, Iasevoli F, et al
    A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
    J Clin Psychiatry. 2017;78:e477-e489.
    PubMed     Text format     Abstract available


  16. BERNARDINI F, Attademo L, Cleary SD, Luther C, et al
    Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.
    J Clin Psychiatry. 2017;78:572-583.
    PubMed     Text format     Abstract available


    April 2017
  17. HAGEN JM, Sutterland AL, Koeter MW, Lutter R, et al
    Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.
    J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972.
    PubMed     Text format     Abstract available


    March 2017
  18. ZHENG W, Xiang YT, Yang XH, Xiang YQ, et al
    Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2017 Mar 28. doi: 10.4088/JCP.16r10782.
    PubMed     Text format     Abstract available


  19. KASTER TS, Daskalakis ZJ, Blumberger DM
    Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10686.
    PubMed     Text format     Abstract available


  20. GERRETSEN P, Voineskos AN, Graff-Guerrero A, Menon M, et al
    Insight Into Illness and Cognition in Schizophrenia in Earlier and Later Life.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10741.
    PubMed     Text format     Abstract available


    February 2017
  21. TAKEUCHI H, Lee J, Fervaha G, Foussias G, et al
    Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    J Clin Psychiatry. 2017;78:223-228.
    PubMed     Text format     Abstract available


    January 2017
  22. JENSEN KG, Correll CU, Ruda D, Klauber DG, et al
    Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    J Clin Psychiatry. 2017 Jan 17. doi: 10.4088/JCP.15m10479.
    PubMed     Text format     Abstract available


  23. HAUSER M, Zhang JP, Sheridan EM, Burdick KE, et al
    Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    J Clin Psychiatry. 2017;78:e28-e40.
    PubMed     Text format     Abstract available


    December 2016
  24. HAMDANI N, Daban-Huard C, Godin O, Laouamri H, et al
    Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
    J Clin Psychiatry. 2016 Dec 6. doi: 10.4088/JCP.15m10133.
    PubMed     Text format     Abstract available


  25. ANDRADE C
    Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance.
    J Clin Psychiatry. 2016;77:e1656-e1660.
    PubMed     Text format     Abstract available


  26. GUINA J, Gupta A, Langleben DD, Elman I, et al
    Clinical Correlates of Oral Glucose Tolerance Test Performance in Olanzapine-Treated Patients with Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2016;77:e1650-e1651.
    PubMed     Text format    


  27. WEAMER EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, et al
    Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.
    J Clin Psychiatry. 2016;77:e1564-e1569.
    PubMed     Text format     Abstract available


  28. IWATA Y, Nakajima S, Caravaggio F, Suzuki T, et al
    Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2016;77:e1557-e1563.
    PubMed     Text format     Abstract available


    November 2016
  29. O'DONNELL CP, Allott KA, Murphy BP, Yuen HP, et al
    Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Nov 8. doi: 10.4088/JCP.15m10185.
    PubMed     Text format     Abstract available


  30. ZHANG C, Chen MJ, Wu GJ, Wang ZW, et al
    Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    J Clin Psychiatry. 2016;77:e1460-e1466.
    PubMed     Text format     Abstract available


    October 2016
  31. BRADFORD DW, Goulet J, Hunt M, Cunningham NC, et al
    A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer.
    J Clin Psychiatry. 2016 Oct 25. doi: 10.4088/JCP.15m10281.
    PubMed     Text format     Abstract available


  32. TANG C, Subramaniam M, Ng BT, Abdin E, et al
    Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective.
    J Clin Psychiatry. 2016 Oct 11. doi: 10.4088/JCP.15m10063.
    PubMed     Text format     Abstract available


  33. SAKURAI H, Suzuki T, Bies RR, Pollock BG, et al
    Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial.
    J Clin Psychiatry. 2016;77:1381-1390.
    PubMed     Text format     Abstract available


    September 2016
  34. BURGERHOUT KM, Kamperman AM, Roza SJ, Lambregtse-Van den Berg MP, et al
    Functional Recovery After Postpartum Psychosis: A Prospective Longitudinal Study.
    J Clin Psychiatry. 2016 Sep 13. doi: 10.4088/JCP.15m10204.
    PubMed     Text format     Abstract available


  35. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions.
    J Clin Psychiatry. 2016;77:e1090-e1094.
    PubMed     Text format     Abstract available


  36. CANGA E, Puerto M, Ortega L, Sole M, et al
    Parental Antecedents of Psychosis Are Associated With Severity of Positive and Negative Symptoms in Schizophrenia Patients.
    J Clin Psychiatry. 2016;77:1201-1202.
    PubMed     Text format    


  37. MISDRAHI D, Tessier A, Swendsen J, Berna F, et al
    Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
    J Clin Psychiatry. 2016;77:e1130-e1136.
    PubMed     Text format     Abstract available


    August 2016
  38. NASRALLAH HA, Newcomer JW, Risinger R, Du Y, et al
    Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.15m10467.
    PubMed     Text format     Abstract available


  39. YOUNG-XU Y, Duh MS, Muser E, DerSarkissian M, et al
    Impact of Paliperidone Palmitate versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.16m10745.
    PubMed     Text format     Abstract available


  40. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 2: Nonpharmacological Interventions.
    J Clin Psychiatry. 2016;77:e964-e967.
    PubMed     Text format     Abstract available


  41. NOTARAS M, Hill RA, Buuse MV
    Dissecting a Genomic Role of BDNF in Schizophrenia and Psychosis.
    J Clin Psychiatry. 2016;77:e1029-e1031.
    PubMed     Text format    


  42. ZHANG XY, Chen DC, Tan YL, Tan S, et al
    BDNF Polymorphisms Are Associated With Cognitive Performance in Schizophrenia Patients Versus Healthy Controls.
    J Clin Psychiatry. 2016;77:e1011-e1018.
    PubMed     Text format     Abstract available


    July 2016
  43. LOEBEL A, Silva R, Goldman R, Watabe K, et al
    Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Jul 19. doi: 10.4088/JCP.16m10698.
    PubMed     Text format     Abstract available


  44. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the Problem.
    J Clin Psychiatry. 2016;77:e844-7.
    PubMed     Text format     Abstract available


    June 2016
  45. CORRELL CU, Maayan L, Kane J, Hert M, et al
    Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2016;77:e746-e756.
    PubMed     Text format     Abstract available


  46. ANDRADE C
    Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    J Clin Psychiatry. 2016;77:e739-e742.
    PubMed     Text format     Abstract available


    May 2016
  47. TOHEN M, Khalsa HK, Salvatore P, Zarate CA Jr, et al
    The McLean-Harvard First-Episode Project: early course in 114 cases of first-episode nonaffective psychoses.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  48. ALAMEDA L, Golay P, Baumann PS, Ferrari C, et al
    Age at the time of exposure to trauma modulates the psychopathological profile in patients with early psychosis.
    J Clin Psychiatry. 2016;77:e612-8.
    PubMed     Text format     Abstract available


  49. SUN L, Qing Y, Yang X, Yang C, et al
    Gene expression profiling of the xMHC region reveals 9 candidate genes in schizophrenia.
    J Clin Psychiatry. 2016;77:e597-9.
    PubMed     Text format    


  50. WEIDEN PJ
    How many treatments before clozapine? medication choices across the spectrum of treatment resistance in schizophrenia.
    J Clin Psychiatry. 2016;77:e594-6.
    PubMed     Text format    


  51. WU CS, Wang SC, Yeh IJ, Liu SK, et al
    Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    J Clin Psychiatry. 2016;77:e573-9.
    PubMed     Text format     Abstract available


  52. FONTANELLA CA, Campo JV, Phillips GS, Hiance-Steelesmith DL, et al
    Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
    J Clin Psychiatry. 2016;77:661-7.
    PubMed     Text format     Abstract available


    April 2016
  53. CLOUTIER M, Sanon Aigbogun M, Guerin A, Nitulescu R, et al
    The economic burden of schizophrenia in the United States in 2013.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  54. LOZANO R, Franco ME, Marin R, Santacruz MJ, et al
    Anemia among schizophrenic patients: influence of clozapine and C-reactive protein.
    J Clin Psychiatry. 2016;77:e467.
    PubMed     Text format    


  55. WEHLER CA, Preskorn SH
    High false-positive rate of a putative biomarker test to aid in the diagnosis of schizophrenia.
    J Clin Psychiatry. 2016;77:e451-6.
    PubMed     Text format     Abstract available


    March 2016
  56. SCHOOLER NR, Marder SR, Chengappa KN, Petrides G, et al
    Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  57. ROCHON-TERRY G, Gruneir A, Seeman MV, Ray JG, et al
    Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  58. WIDSCHWENDTER CG, Rettenbacher MA, Kemmler G, Edlinger M, et al
    Bilirubin concentration correlates with positive symptoms in patients with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  59. KANTROWITZ JT, Sharif Z, Medalia A, Keefe RS, et al
    A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


    February 2016
  60. HUI L, Han M, Huang XF, Ye MJ, et al
    Association between DbetaH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  61. DRAKE RJ, Addington J, Viswanathan AC, Lewis SW, et al
    How age and gender predict illness course in a first-episode nonaffective psychosis cohort.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  62. MILLER BJ, Dias JK, Lemos HP, Buckley PF, et al
    An open-label, pilot trial of adjunctive tocilizumab in schizophrenia.
    J Clin Psychiatry. 2016;77:275-6.
    PubMed     Text format    


  63. VINOGRADOV S, Schulz SC
    Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:12-6.
    PubMed     Text format     Abstract available


  64. GREEN MF
    Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:8-11.
    PubMed     Text format     Abstract available


  65. SCHULZ SC, Murray A
    Assessing cognitive impairment in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:3-7.
    PubMed     Text format     Abstract available


  66. HIPPMAN C, Ringrose A, Inglis A, Cheek J, et al
    A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses.
    J Clin Psychiatry. 2016;77:e190-8.
    PubMed     Text format     Abstract available


    January 2016
  67. BORLIDO C, Remington G, Graff-Guerrero A, Arenovich T, et al
    Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry. 2016;77:e14-20.
    PubMed     Text format     Abstract available


  68. DIMITROV DH, Lee S, Yantis J, Honaker C, et al
    Elevated serum levels of high-sensitivity C-reactive proteins are associated with severe delusional symptoms in a subgroup of patients with schizophrenia.
    J Clin Psychiatry. 2016;77:131-2.
    PubMed     Text format    


  69. CITROME L, Durgam S, Lu K, Ferguson P, et al
    The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.
    J Clin Psychiatry. 2016;77:109-15.
    PubMed     Text format     Abstract available


  70. LEO RJ, DuBois RL
    A case of olfactory groove meningioma misdiagnosed as schizophrenia.
    J Clin Psychiatry. 2016;77:67-8.
    PubMed     Text format     Abstract available


  71. CORRELL CU, Citrome L, Haddad PM, Lauriello J, et al
    The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    J Clin Psychiatry. 2016;77.
    PubMed     Text format     Abstract available


    December 2015
  72. ZHANG XY, Fan FM, Chen DC, Tan YL, et al
    Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  73. MAYORAL-VAN SON J, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Moreno T, et al
    Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  74. DURGAM S, Cutler AJ, Lu K, Migliore R, et al
    Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
    J Clin Psychiatry. 2015;76:e1574-82.
    PubMed     Text format     Abstract available


    November 2015
  75. HUNG GC, Liu HC, Yang SY, Pan CH, et al
    Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  76. GERSTENBERG M, Hauser M, Al-Jadiri A, Sheridan EM, et al
    Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
    J Clin Psychiatry. 2015;76:e1449-58.
    PubMed     Text format     Abstract available


    October 2015
  77. PARELLADA M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, et al
    Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  78. LURIE I, Yang YX, Haynes K, Mamtani R, et al
    Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  79. VAN SCHEPENDOM J, Yu W, Gielen J, Laton J, et al
    Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?
    J Clin Psychiatry. 2015;76:e1292-9.
    PubMed     Text format     Abstract available


    September 2015
  80. DAVIS JM, Ramsden CE
    Do antipsychotics cause hip fractures? Promise and pitfalls of big data.
    J Clin Psychiatry. 2015;76:e1155-6.
    PubMed     Text format    


    August 2015
  81. RANNING A, Munk Laursen T, Thorup A, Hjorthoj C, et al
    Serious mental illness and disrupted caregiving for children: a nationwide, register-based cohort study.
    J Clin Psychiatry. 2015;76:e1006-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: